EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access

Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy

Alberto Aimo iD, Martina Nesti iD, Giuseppe Vergaro iD, Ammar M Killu iD, Dimitrios Bampatsias, Daniela Tomasoni iD, Cinzia Forleo iD, Francesco Musca iD, Matteo Serenelli, Julie Rosenthal iD, Sergio L Teruya iD, Nader J Al-Shakarchi iD und 25 weitere

Journal of the American Heart Association · 18.11.2025 · 14 (22)

DOI: 10.1161/jaha.125.043049 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 18.11.2025. Verfasst von Alberto Aimo und 36 weiteren Autor:innen. Beteiligte Einrichtung: Scuola Superiore Sant'Anna Pisa Italy. Hauptthemen laut MEDLINE: Cardiac Resynchronization Therapy, Amyloid Neuropathies, Familial, Ventricular Remodeling, Cardiomyopathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transthyretin amyloid cardiomyopathy (ATTR‐CM) has a specific pathophysiology, with myocardial stiffening and systolic dysfunction only in advanced stages. We aimed to investigate the response to cardiac resynchronization therapy (CRT) in ATTR‐CM compared with heart failure.

Methods

In this multicenter, observational study, patients with ATTR‐CM receiving CRT (n=101) were matched to patients without amyloid cardiomyopathy by sex, age, and implantation type (CRT with versus without defibrillator versus conduction system pacing, upgrade versus first implant). We evaluated changes in QRS duration and echocardiographic parameters following CRT implantation and at the most recent available assessments. The study end points were all‐cause death alone or combined with heart failure hospitalization.

Results

Patients with ATTR‐CM (median age, 76 [interquartile range, 72–83] years, 98% men, left ventricular (LV) ejection fraction 30% [26–33]) showed greater QRS shortening after CRT implantation ( P =0.012), but not after a median of around 1 year ( P =0.152). There were no significant differences in the absolute LV ejection fraction changes immediately after implantation (+7 [+2/+10] versus +3 [0/+9] units; P =0.124), or to the last echo ( P =0.796), which was performed after 1.3 years in patients with ATTR‐CM and 2.9 years in patients without amyloid cardiomyopathy. Patients with ATTR‐CM had a shorter survival than controls ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac Resynchronization TherapyAmyloid Neuropathies, FamilialVentricular RemodelingCardiomyopathiesHeart FailureVentricular Function, LeftHumansMaleFemaleAgedAged, 80 and overTreatment OutcomeStroke VolumeEchocardiographyTime FactorsElectrocardiography

Stichwörter der Autor:innen

CRTcardiac amyloidosiscardiac resynchronization therapyconduction system pacingoutcomeremodelingtransthyretin

Autor:innen und Institutionen

  • Scuola Superiore Sant'Anna Pisa Italy.
  • Fondazione Toscana Gabriele Monasterio Pisa Italy.
  • Mayo Clinic Rochester MN USA.
  • Columbia University New York City NY USA.
  • ASST Spedali Civili di Brescia and University of Brescia Italy.
  • University Hospital of Bari Italy.

ORCID-Profile: Alberto Aimo, Martina Nesti, Giuseppe Vergaro, Ammar M Killu, Daniela Tomasoni, Cinzia Forleo, Francesco Musca, Julie Rosenthal, Sergio L Teruya, Nader J Al-Shakarchi, Vincenzo Castiglione, Aldostefano Porcari, Vera Fico, Andrea I Guaricci, Giacomo Tini, Alberto Cipriani, Simone Longhi, Cristina Chimenti, Marco Metra, Martha Grogan, Federico Perfetto, Francesco Cappelli, Marco Merlo, Gianfranco Sinagra, Mathew S Maurer, Ahmad Masri, Michele Emdin

Zitieren

APA

Aimo, A., Nesti, M., Vergaro, G., Killu, A. M., Bampatsias, D., Tomasoni, D., Forleo, C., Musca, F., Serenelli, M., Rosenthal, J., Teruya, S. L., Al-Shakarchi, N. J., Tameze, M. S., Castiglione, V., Nicolai, A., Panichella, G., Saro, R., Porcari, A., Sinigiani, G., …, & Emdin, M. (2025). Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy. Journal of the American Heart Association, 14(22). https://doi.org/10.1161/jaha.125.043049

Vancouver

Aimo A, Nesti M, Vergaro G, Killu AM, Bampatsias D, Tomasoni D, et al. Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy. Journal of the American Heart Association. 2025;14(22). doi:10.1161/jaha.125.043049

BibTeX
@article{Aimo2025,
  author = {Aimo, Alberto and Nesti, Martina and Vergaro, Giuseppe and Killu, Ammar M and Bampatsias, Dimitrios and Tomasoni, Daniela and Forleo, Cinzia and Musca, Francesco and Serenelli, Matteo and Rosenthal, Julie and Teruya, Sergio L and Al-Shakarchi, Nader J and Tameze, Mariel S and Castiglione, Vincenzo and Nicolai, Alessio and Panichella, Giorgia and Saro, Riccardo and Porcari, Aldostefano and Sinigiani, Giulio and Fico, Vera and Frau, Elisa and Matar, Reem and Guaricci, Andrea I and Tini, Giacomo and Cipriani, Alberto and Musumeci, Maria B and Longhi, Simone and Chimenti, Cristina and Metra, Marco and Grogan, Martha and Perfetto, Federico and Cappelli, Francesco and Merlo, Marco and Sinagra, Gianfranco and Maurer, Mathew S and Masri, Ahmad and Emdin, Michele},
  title = {Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {22},
  doi = {10.1161/jaha.125.043049}
}
Kostenlos starten →